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Abstract
Macrophage infiltration in white adipose tissue (wAT) underlies the development of 
the obesity-associated chronic inflammatory state. in this article current knowledge is 
reviewed with respect to adipocyte-driven mechanisms responsible for macrophage 
recruitment and activation in wAT. Adipocyte hypertrophy, adipocyte hypoxia, altered 
adipokine profiles under stress conditions and adipocyte death is discussed. in ad-
dition, new data is provided that shows phosphatidylserine exposure in human adi-
pocytes under hypoxic conditions. This may represent an additional mechanism that 
plays a role in macrophage recruitment in wAT.   
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Introduction
Obesity is characterized by a chron-
ic, low-grade inflammatory state of 
the adipose tissue. This inflamma-
tory state is most likely initiated by 
changes in the adipocyte phenotype 
and fuelled by infiltrating macro-
phages producing pro-inflammatory 
cytokines and reactive oxygen species. 
The development of the inflammatory 
state in white adipose tissue (WAT) is 
considered an event that underlies the 
development of metabolic complica-
tions during obesity. To become in-
flammatory in the WAT, macrophages 
need to be recruited and activated. 
Adipocyte hypertrophy, changed 
adipokine profiles and adipocyte 
death are important events related to 
macrophage recruitment and activa-
tion. However, the mechanism(s) for 
macrophage-adipocyte interaction in 
WAT are still not completely resolved. 
Macrophages are predominantly 
found in hypoxic areas in WAT and 
form so-called crown-like structures 
around dead adipocytes. Surface ex-
posed phosphatidylserine (PS), result-
ing from a collapse of membrane lipid 
asymmetry during cell death, provides 
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a recognition signal for phagocytic macrophages. In this review 
an update is provided on adipocyte-derived mechanisms for 
macrophage infiltration and activation. In addition, preliminary 
data is presented showing PS exposure in adipocytes under hy-
poxic stress, which may act as a mechanism for adipocyte-mac-
rophage interactions.
Macrophages in WAT
Macrophages are detected in WAT of rodents and humans (re-
viewed in (1) and their numbers are positively correlated with 
WAT mass. Increased numbers are found in WAT of genetically 
obese mice (2,3) and diet-induced obese mice (3,4) and in sub-
cutaneous (2) and visceral WAT (5) of obese subjects. In addi-
tion, a reduction of the number of macrophages in subcutaneous 
WAT was observed after surgery-induced weight loss (6). These 
results indicate a dynamic relationship between WAT mass and 
macrophage infiltration. 
Two types of macrophages have been described in WAT: the 
‘resident’ M2 macrophages which appear involved in adipogene-
sis and the M1 type macrophages which are denoted as infiltrat-
ing cells (7). Infiltrated macrophages contribute to the chronic 
low-grade inflammatory state found in adipose tissue (2,3,8) and 
are considered to progress insulin resistance (9). With respect to 
the presence of macrophages in the different WAT depots, an in-
creased number of macrophages was found in visceral fat com-
pared to subcutaneous fat both in mouse models (2,10,11) and 
human (12,13). This suggested a more prominent role for vis-
ceral fat in relation to the onset of insulin resistance. However, 
recently, pro-inflammatory macrophages were detected in sub-
cutaneous fat, where the density of crown structures was higher 
in obese woman with metabolic syndrome (ObMS) compared 
to ‘normal’ obese woman (Ob) (14). In addition, the crown den-
sity was higher in subcutaneous fat compared to visceral fat in 
ObMS. Although these results seem contradictive to the idea 
that visceral WAT is primarily responsible for induction of insu-
lin resistance (15), they are in line with a another study showing 
that subcutaneous fat, but not visceral fat, was correlated with 
insulin resistance in lean and obese men (16). In addition, it was 
shown before that crown-like structure density in subcutaneous 
WAT of obese woman correlated with insulin resistance (17). 
Furthermore, the results are consistent with a greater size of 
subcutaneous adipocytes compared to visceral adipocytes and 
support the view that visceral obesity is a consequence rather 
than a cause for insulin resistance (18). Apparently, macrophage 
infiltration occurs in both types of human WAT and both con-
tribute to development of insulin resistance. Notably, adipocyte 
size seems an important factor in macrophage infiltration. 
Recruited macrophages during diet-induced obesity have 
increased inflammatory properties in contrast to macrophages 
already present in adipose tissue (19). In addition, it appeared 
that non-adipose cells in human adipose tissue are responsible 
for the majority of inflammatory factors secreted by the adipose 
tissue (20), which can be reversed by weight loss (21). Together, 
this indicates that novel recruited macrophages rather than adi-
pose-residing macrophages are involved in the obesity-induced 
pro-inflammatory state and may initiate insulin resistance. 
Adipose tissue hypoxia and inflammation
Macrophages have been detected in hypoxic areas in mouse 
adipose tissue, together with cytotoxic T-cells (4). Although 
hypoxic areas have been observed in WAT from obese mouse 
and humans (22-24), presence of macrophages in hypoxia ar-
eas in human WAT has not been demonstrated yet. However, as 
will be discussed later, macrophages in human WAT surround 
necrotic adipocytes (25). Since the adipose tissue is highly in-
nervated (26), the idea raised that the extensive expansion of 
adipocytes during pre-adipocyte hypertrophy may cause a di-
minished blood supply by restricted capillaries. Alternatively, 
due to expansion of the adipocyte cell volume the O2 diffusion 
distances within the tissue may be reduced (27). Both can lead 
to hypoxic conditions. The hypoxia hypothesis was proposed 
first by Trayhurn and Wood when they suggested that hypoxia 
could play a role in adipose-tissue inflammatory processes (28). 
It is known that human pre-adipocytes subjected to hypoxic 
conditions are inhibited in their differentiation process (27). 
In addition, mature mouse and human adipocytes exposed to 
hypoxia show an adipokine deregulation with increased ex-
pression of pro-angiogenic and pro-inflammatory factors (29-
31). Furthermore, we showed that hypoxia induces lipolysis in 
human adipocytes (Rosenow et al., in preparation). Increased 
release of free fatty acids from adipocytes may trigger pro-in-
flammatory responses in M1 macrophages by targeting Toll-like 
receptor 4 (TLR4) (32). 
The key regulator for transmission the hypoxic response 
in adipocytes is hypoxia-induced factor 1a (HIF-1a) (33). 
Stabilization of HIF-1a either by chemically induced hypoxia or 
by low oxygen tension showed increased expression and secre-
tion of inflammation-related adipokines such as interleukin-6 
(IL-6), macrophage inhibitory factor (MIF) and plasminogen 
activator inhibitor-1 (PAI-1) with a concomitant decreased se-
cretion of the insulin sensitizer adiponectin (33). Currently, our 
group performs a proteomics study on the effect of hypoxia on 
adipokine profiles from human adipocytes (Rosenow et al., in 
preparation). In a transgenic mouse model, constitutively ex-
pressing HIF-1a, the WAT showed fibrotic lesions with associat-
ed insulin resistance (34). Together, it is increasingly recognized 
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It has been shown that conditioned medium derived from hu-
man adipocyte cultures stimulates monocyte diapedesis through 
endothelial cell layers (49). The same was observed when this 
medium was de-lipidated to remove adipocyte-released glycerol 
and fatty acids. In contrast, monocyte diapedesis was blocked 
when the medium was heated to denature proteins. These re-
sults clearly show that human adipocyte-derived adipokines 
play an important role in monocyte infiltration. Monocyte in-
filtration involves endothelial cell surface adhesion molecules 
such as ICAM-1, VCAM-1, PECAM-1, P-selectin and E-selectin 
(50,51). By the action of adhesion molecules monocytes first 
attach to the endothelial cell surface and are subsequently ar-
rested by chemokine-activated integrins. Firm adhesion is fol-
lowed by diapedesis of the monocytes through the endothelial 
cell-cell junctions (52). To prevent uncontrolled inflammatory 
reactions, the monocyte entry is strictly controlled by expres-
sion of the specific adhesion molecules on the endothelial cell 
surface (51). Expression of ICAM-1 and PECAM-1 on adipose 
tissue endothelial cells was increased by secretion medium from 
human adipocytes, which provided an explanation for the in-
creased monocyte diapedesis (49). 
In mice, the monocyte chemoattractive protein 1 (MCP-1) 
was identified as an adipocyte-derived factor involved in macro-
phage recruitment (53). However, macrophage recruitment was 
not impaired in Mcp-1 -/- knock out mice (54,55), suggesting 
that MCP-1 might not be a critical factor in macrophage recruit-
ment in mice. With respect to humans, increased circulating 
MCP-1 levels are observed in obese subjects, which could be 
reversed upon weight loss (56). However, it is not clear whether 
human adipocyte-derived MCP-1 alters the expression of en-
dothelial adhesion molecules and as such stimulates macro-
phage recruitment. On the other hand, increased concentrations 
of recombinant human leptin induced expression of adhesion 
molecules on endothelial cells and resulted in increased trans-
migration of monocytes through an endothelial cell layer (49). 
Together, there is clear evidence that adipokines are involved in 
macrophage recruitment. However, much is still to be discov-
ered about the key human adipokines that are responsible for in-
duction of macrophage recruitment. We are currently develop-
ing a novel method to identify adipokine-receptor interactions. 
This may be a helpful approach to study intercellular communi-
cation and may shed light on human adipokines responsible for 
macrophage diapedesis. 
Intervention of adipose tissue macrophage infiltration
Although thiazolidinediones (TZDs) received negative attention 
due to the withdrawal of troglitazone and controversial publica-
tions regarding rosiglitazone (57), they provided important in-
that hypoxia in WAT plays an important role in changing the 
adipocyte phenotype, which may contribute to recruitment and 
activation of macrophages. 
Adipokines and macrophage infiltration 
The adipogenic process comprises pre-adipocyte hypertrophy 
and proliferation of (novel recruited) pre-adipocytes (35,36). 
However, in T2D patients it is shown that expression of genes 
involved in pre-adipocyte proliferation was decreased (37). This 
suggests that impaired adipogenesis, which leads to hypertro-
phy of existing pre-adipocytes, is involved in the onset of insu-
lin resistance. As stated above, hypoxia also inhibits adipocyte 
proliferation. Apparently, cessation of adipocyte differentiation 
in WAT, together with a increased stress levels due to hypoxic 
conditions contributes to inflammatory conditions. During the 
last decade it became clear that adipokines released from the 
adipose tissue under stress conditions play an important role in 
the pathogenesis of obesity-related complications (28,38,39). 
Currently, many different adipokines are known (27,40-43), 
albeit with a considerable discrepancy between rodent and hu-
man adipokine expression. For instance, adipsin showed de-
creased expression in obese mice and was originally thought to 
protect against obesity. In contrast, subsequent human studies 
failed to confirm this hypothesis and showed increased adipsin 
levels in obese persons (44). In addition, tumor necrosis factor-
alpha (TNF-a) is expressed in mouse adipose tissue and is re-
leased into the circulation, while in human it acts locally in the 
adipose tissue and is not released into the circulation (45). Even 
more contrasting is resistin that is produced in mouse adipose 
cells but not in human adipocytes (46). Together, these results 
show that, despite the value of rodent studies, a one-to-one ex-
trapolation of data from animal models to human adipokine 
action is inexpedient. It is therefore necessary to focus on hu-
man adipokines in order to understand the link between obesity 
and metabolic complications in man, and particularly the role 
of adipokines in macrophage recruitment and activation in hu-
man WAT. 
In obese insulin-resistant subjects, macrophage infiltration 
into adipose tissue is related to vascular endothelial dysfunction, 
probably caused by the adipose-tissue inflammatory response 
(17). To become pro-inflammatory in WAT, macrophages un-
dergo a sequence of events that starts with infiltration as mono-
cytes from the blood into the fat tissue (10,47). Once inside 
the tissue, monocytes are activated and differentiate into pro-
inflammatory macrophages. This process is fuelled by increased 
expression of pro-inflammatory adipokines, like TNF-a, and an 
increased release of free fatty acids that target the TLR4 receptor 
on macrophages (48). 
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formation on the role of PPARg as a key regulator for insulin sen-
sitivity and anti-inflammatory mechanisms (58). TZDs antago-
nize pro-inflammatory conditions by decreasing the expression 
of T-cell-derived cytokines, endothelial adhesion molecules and 
endothelial chemokines (59-61). This suggests that TZDs might 
impair monocyte recruitment in adipose tissue by a modulation 
of endothelial cells. However, as PPARg agonists, TZDs strongly 
activate pre-adipocyte hypertrophy (62), which is considered a 
risk factor for metabolic complications. As such, the effect medi-
ated by TZDs seems paradoxal. Our group provided an explana-
tion for this discrepancy by showing that rosiglitazone reduces 
adipokine expression and induces a fat-catabolizing metabolism 
in mature 3T3-L1 adipocytes (63, 64). Whether this also occurs 
in cultured human adipocytes is unclear. As such, it remains to 
be discovered whether the action of TZDs on human adipocytes 
plays a role in the immune-modulating effects of these drugs on 
endothelial cells.    
Adipocyte death
Macrophages particularly surround large adipocytes (2) and the 
frequency of adipocyte death is positively correlated with adi-
pocyte size (25,65). Furthermore, over 90% of macrophages in 
mouse and human WAT are localized to dead adipocytes (25). 
This suggests that adipocyte death is strongly associated with 
macrophage recruitment. 
Adipocyte death in WAT is a physiological process since 
about 10% of fat cells in adults are renewed annually. However, 
the total number of adipocytes remains constant in lean and 
obese, which indicate a dynamic, but tightly regulated, fat cell 
turnover in man (66). Obese persons have more adipocytes and 
thus the absolute number of dead adipocytes is expected to be 
higher (67). This may lead to a sustained macrophage recruit-
ment and development of a chronic inflammatory state. 
In mice, the frequency of dead adipocytes in epididymal fat 
increased in a time-dependent manner during diet-induced 
obesity for 16 weeks (10). This was coincided with increased fat 
depot weight, an increased number of infiltrated macrophages, 
induced expression of TNF-a, MCP-1, IL-10 and induction 
of insulin resistance. However, after 20 weeks the number of 
adipocytes was restored and expression of macrophage mark-
ers was declined, although the number of dead adipocytes re-
mained constant in subcutaneous WAT. These results suggest 
that macrophages at first function in adipose tissue remodeling. 
However, under persistent inflammatory conditions macro-
phages remain activated and fuse to form multinucleate giant 
cells (68, 69), a hallmark for adipose tissue macrophages. One 
can imagine that a deregulation of adipokine expression dur-
ing adipocyte hypertrophy and hypoxia provides a continuous 
source of pro-inflammatory cytokines that attract and activate 
macrophages. A potential additional mechanism is presented 
here by showing that mature adipocytes subjected to hypoxia 
expose phosphatidylserine (PS), a molecule that serves as a rec-
ognition site for phagocytic macrophages (70).
Membrane lipid asymmetry and phosphatidylserine 
exposure  
The cellular plasma membrane is built up as a lipid bilayer. 
The majority of this lipid bilayer consists of four phospholip-
ids: phosphatidylserine (PS), phosphatidyl-ethanolamine (PE), 
phosphatidylcholine (PC) and sphingomyelin (Sph) (71). In 
quiescent cells these are asymmetrically distributed, with PC 
and SM predominantly present at the outer leaflet and PE and 
PS mainly present at inner leaflet. The asymmetric distribution 
of the phospholipids is maintained by the action of three types 
of lipid transporters: flippases, floppases and scramblase(s) (71, 
72), see also Fig. 1. A flippase can ‘flip in’ PS and PE from the 
outer to the inner leaflet, against their concentration gradients. 
For this reason this transporter is also referred to as an amino-
phospholipid translocase. The half time of PS exchange is 5-10 
minutes, for PE this goes at a slower rate. Lipid translocation is 
an energy consuming process as one molecule ATP is hydro-
lyzed for every lipid transported. This phospholipid transloca-
tion is also present in intracellular membranes, for example mi-
tochondria and the ER. Floppases ‘flop out’ PC, PS and PE to the 
outside of the membrane. For this process less ATP is required 
and it works 10 times slower than the flippase-mediated translo-
cation. The floppase appears to be identical to the ABC transport 
protein ABCC1 (71).
Flippases and floppases are both constantly in an active state 
to maintain the bilayer asymmetry. Both make sure that all 
phospholipids are slowly transported to the outer leaflet, while 
PS and PE are quickly transported back to the cytosolic side. 
The third type of lipid transporter is a so-called scramblase, 
which scramble the membrane asymmetry within minutes, by 
randomly switching phospholipids from either side of the mem-
brane bilayer to the other side. For long times protein candidates 
for this type of transport activity remained elusive, but recently 
TMEM16F was identified as a protein involved in scrambling 
mouse B-cell membranes (73). Furthermore, a truncated form 
of this protein was found patients with Scott syndrome, a rare 
congenital bleeding disorder caused by an impaired platelet pro-
coagulant activity (74). By the scramblase activity, PS is exposed 
rapidly to the outer surface of the cell. While the other trans-
porters are ATP dependent, the scramblase mainly relies on a 




PS-exposure in physiological conditions
Several physiological processes depend on PS exposure. For in-
stance, platelet activation and coagulation near injuries is PS-
mediated. With respect to scavenging of non-functional cells, 
PS exposure initiates the binding of macrophages, followed by 
phagocytosis (75). Changes in intracellular ATP and Ca2+ are 
correlated with a collapse of the mitochondrial membrane po-
tential (76). Apoptotic events, which make the mitochondrial 
membrane permeable, result in the leakage of electrolytes, by 
which this collapse will be induced. At the same time the perme-
able membrane results in the leakage of mitochondrial contents, 
such as ATP and Ca2+, into the cytoplasm, that leads to expo-
sure of PS to the outer leaflet of the membrane. Furthermore, 
ER-stress leads to PS exposure (77) and ER-stress markers are 
observed in hypoxic adipocytes (24). As mentioned before, mac-
rophages in WAT surround necrotic adipocytes in crown-like 
structures, scavenging residual adipocyte material and ultimate-
ly form multinucleate giant cells (25). Since macrophages partic-
ularly surround dead adipocytes in hypoxic areas it is tempting 
to speculate that adipocytes subjected to hypoxia expose PS as 
part of a stress response. As such we hypothesized that PS-ex-
position is a recognition signal for macrophages to interact with 
adipocytes that are under hypoxic stress.
PS-exposure in adipocytes
PS exposition in adipocytes has not been demonstrated before. 
As such, the ability of human adipocytes to expose PS was in-
vestigated. For this, human SGBS adipocytes were used and 
these were incubated with ionomycin, a calcium ionophore 
that induces a collapse of membrane phospholipid asymme-
try, which results in PS-exposure. PS was detected by specific 
binding of fluorescently labelled Annexin5 at the extracellu-
lar site of the plasma membrane. Pre-incubating the cells with 
EDTA diminished binding of Annexin5, which confirmed 
that inomycin-induced PS-exposure is Ca2+-dependent (Fig. 
2). Subsequently, SGBS cells were exposed to hypoxic condi-
tions during the course of differentiation. PS-exposure was 
only measured at day 14 of differentiation. No PS-exposure 
was observed in the control adipocytes (Fig. 3). These results 
show that adipocytes are able to expose PS. Furthermore, they 
indicate that only mature adipocytes expose PS under hypoxic 
conditions. 
Figure 1. example of transporter-controlled exchange of phospholipids between leaflets of the platelet plasma membrane. 
Unidirectional transport of phosphatidylserine (PS) and phosphatidylethanolamine (Pe) by flippases is directed inward. 
Floppases are involved in the outward movement of phosphatidylcholine (PC) and sphingomyelin (SPH). Bidirectional (a-specif-
ic) phospholipid transport is catalyzed by a scramblase upon activation with Ca2+. As such, it promotes a collapse of membrane 
phosphoplipid asymmetry resulting in PS exposure at the outer leaflet. (According to ref. 71)
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Figure 3. Hypoxia induces PS exposure in mature SGBS adipocytes. SGBS pre-adipocytes (prea’s) and adipocytes (4-14 days of 
differentiation) were subjected to hypoxic conditions (16 hrs., 100 mM CoCl2). After 14 days of differentiation a mixed popula-
tion of cells was observed with FiTC-negative and FiTC-positive (~10-20% of the cell population). All FiTC-positive cells were also 
positive for propidium iodide (Pi). This demonstrates a loss of membrane integrity. Bar indicates 0.25 mm.
Figure 2. PS exposure in human SGBS (pre)adipocytes. ionomycin incubation (45 min., 5 μM) resulted in annexinA5-FiTC bind-
ing to the cells. Binding of annexinA5 was diminished in the presence of eDTA (0.1 mM), showing that this is Ca2+- dependent. 
Bar indicates 0.25 mm.
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Interaction partners for PS-mediated macrophage 
docking
There seems no single PS-receptor (78). T-cell immunoglobulin- 
and mucin-domain-containing molecule 4 (TIM-4) is involved 
in macrophage binding since antibodies against this protein 
inhibited apoptotic cell removal (79). In addition, blocking the 
TIM-4-TIM-1 pathway resulted in decreased macrophage infil-
tration in murine injured liver tissue (80). Stabilin-2 is identi-
fied as another receptor molecule for PS. Blocking of stabilin-1 
resulted in impaired PS-mediated clearance of defective eryth-
rocytes by macrophages (81). In recent years it has become clear 
that docking to PS involves additional molecules that acts as 
bridging partners between macrophages and PS-exposing cells 
(78). Growth arrest-specific 6 (GAS6) is a protein that has a 
high affinity for PS (82), but not for other phospholipids (83). 
GAS6 is also the ligand for the MerTK receptor (84), a tyrosine 
kinase receptor expressed on active macrophages. In this way, 
GAS6 forms a molecular bridge between PS-exposing cells and 
macrophages. In GAS6-/- mice macrophage diapedesis through 
endothelial cells was impaired (82). It is known that GAS6 is 
expressed in 3T3-L1 adipocytes and is secreted via microvesicles 
(85). The presence of GAS6 in human adipocytes is currently 
unknown. 
Another bridging molecule for PS-macrophage interaction 
is milk fat globule-EGF factor 8 (MFG-E8) (86). This protein 
has a PS-binding domain and is secreted by activated macro-
phages [17,18]. It mediates the adhesion of monocytes express-
ing the αvβ3 integrin to exposed PS via its RGD domain (87). 
Hanayama et al (86) transformed NIH3T3 to express the αvβ3 in-
tegrin and showed a significantly elevated binding of these cells 
to PS-coated platelets in the presence of MFG-E8. With a mu-
tant form of MFG-E8 adhesion was not observed, while higher 
concentrations of MFG-E8 showed increased binding of αvβ3 
expressing NIH3T3 cells. Apparently, the sole MFG-E8 bridge is 
enough to induce macrophage-PS interaction. MFG-E8 expres-
sion was elevated in hypertrophic adipose tissue of diet-induced 
obese C57BL/6 mice (88). Together, these results show that PS-
mediated macrophage docking is a regulated process involving 
several different proteins. Some of these are expressed by adi-
pocytes. 
Resume: a model for macrophage recruitment, 
activation and interaction in WAT
To summarize, macrophage recruitment and activation in 
WAT seems an adipocyte-driven process that involves adi-
pocyte hyperplasia, secretion of pro-inflammatory adipokines 
and, as shown here, PS-exposure. In the course of obesity the 
WAT expands by adipocyte hypertrophy and hyperplasia, both 
events result in a considerable change in adipokine profiles. 
Adipocyte hypertrophy is associated with hypoxia, most likely 
to due blocking of blood and oxygen supply. Hypertrophic, but 
particularly hypoxic adipocytes, secrete pro-inflammatory adi-
pokines, which stimulate macrophage diapedesis. Furthermore, 
pro-inflammatory adipokines may stimulate macrophages to 
become activated. Stress on mature adipocytes, either by hy-
poxia or lipid overload, induces adipocyte death, which is pro-
ceeded by PS-exposure. PS behaves as a so-called ‘eat-me’ signal 
for macrophages. With the aid of additional bridging molecules 
macrophages bind to adipocytes to start the phagocytic process, 
which is fuelled by the release of pro-inflammatory cytokines. 
Prolonged recruitment and activation of macrophages may thus 
lead to a chronic inflammatory state that ultimately results in 
metabolic complications. 
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